Tonix Pharmaceuticals has presented data for TNX-102 SL (cyclobenzaprine HCI sublingual tablets, 2.8 mg), its investigational new drug, at the American Society for Clinical Pharmacology and Therapeutics 2016 Annual Meeting, held March ... Read more